MagForce AG (MGFRF)
MagForce AG operates in the Medical - Devices industry of the Healthcare sector, headquartered in Berlin, DE. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $11,973. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -3004.2%. Its beta of 3.02 implies it has historically moved more than the broad market.
MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoActivator, a device engineered to generate magnetic fields. Established in 1997, MagForce AG maintains its primary office in Berlin, Germany.
MagForce AG is most often compared with the following Healthcare names: